Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

against repair-contributing may sustain damage across tissues

In populations, may gain an advantage only above a , allowing a brief shift in survival to restore both tissues. A transition that persists when is held constant would reject this proposed explanation.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionWhole body

Ageing mechanism

Main connectionAltered intercellular communication

Direction

Kind of knowledge gap

No current scientific result answers this requirement.Void gap

A double ring marks the main placement where a group contains several values.

Lens
Evolutionary frequency dependent selection
Goal
Затухание взаимного усиления возрастных повреждений
Competing hypotheses
3
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
7 / 10Few extra conditions
10 / 10Completeness of the answer
5 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
4 / 10Silver-bullet potential
4 / 10Support from research
Poster: Repair-contributor loss sustains tissue damage
PosterOpen the sheet full size2026-09-30

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Fibroblast or stromal cell

    Cells that contribute to the maintenance and repair of the surrounding tissue environment

    Where this hypothesis actsAgeing stroma with heritable differences in repair contribution and damage sustained across tissues

    Hypotheses on this target 1
    Stromal cellsSenomorphic suppression. Hypotheses on this target 0Reprogramming. Hypotheses on this target 0Transplantation. Hypotheses on this target 0Elimination. Hypotheses on this target 0Population balance. Hypotheses on this target 11
    • Senomorphic suppression
    • Reprogramming
    • Transplantation
    • Elimination
    • Population balance1

    What is proposed

    Population balance

    Shift the population balance above the threshold favouring repair-contributing cells

    With whatNot stated in the record

    HowBriefly change relative cell survival in one component of the intertissue system to raise the proportion of repair-contributing cells above the threshold

    Possible result

    Possible sustained repair in both tissues through favouring repair-contributing cells

    From the recordКраткое изменение относительной выживаемости в одном звене, переводящее долю восстановительных клеток выше порога, запускает устойчивое восстановление обеих тканей.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cellsStromal cells. Hypotheses on this target 1Stromal cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Damage in one tissue may help keep damage going in another, making lasting recovery depend on breaking their mutual reinforcement. The unexpected move is to change which tissue-supporting cells survive: a brief intervention would make cells that contribute to repair common enough to retain an advantage after treatment ends. This is a proposal generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. The proposal assigns tissue-supporting cells two behaviors that persist through division: contributing to repair or contributing less while using its benefits.
  2. jointly improve their surroundings, with enough of the benefit remaining among nearby contributors.
  3. Below the proposed , lose ground to cells that contribute less.
  4. Damage passing between tissues further worsens conditions for and sustains their disadvantage.
  5. A brief change in relative survival raises contributors above the threshold, switching them from a shrinking minority to a population that gains ground.
  6. The growing share of is predicted to weaken repeated damage and sustain recovery in both tissues after the intervention ends.
A picture for it

Imagine a shared garden where tending plants takes effort, but the harvest mainly benefits nearby gardeners. When enough neighbors tend their plots, continuing becomes worthwhile; when too few do, neglect spreads.

Where the picture breaks: Cells do not weigh effort or choose cooperation. The proposal requires measurable differences in survival or growth, behavior that persists through division, and preferential local benefits; the garden picture establishes none of these.

  1. Master questionstep 01 of 04

    A single targeted intervention might benefit several bodily systems if it interrupts a shared cause through which processes of aging reinforce one another.

    Rests on: The goal is to find life-extension ideas that act on a common causal link rather than addressing each source of damage separately.

    Assumption

    The search assumes that mutually reinforcing processes of aging may contain a shared link whose interruption benefits multiple systems. The supplied material does not establish such a link.

  2. Goal pillarstep 02 of 04

    Age-related damage would become less persistent if its sources stopped strengthening one another.

    Rests on: The master question explicitly identifies mutual reinforcement of aging processes as a possible target for a shared intervention.

    Stated in the chain
  3. Gap questionstep 03 of 04

    Damage exchanged between tissues might have a threshold, a boundary separating damage that sustains itself from damage that fades. The question is whether briefly interrupting one link can cross that boundary and produce lasting recovery, with the effect distinguished from a reduction in the ordinary daily burden on tissues.

    Rests on: The preceding goal calls for weakening mutual reinforcement. This stage asks whether that weakening could produce a lasting switch rather than merely a temporary reduction in damage.

    Stated in the chain
  4. Hypothesisstep 04 of 04

    , cells that support and maintain the tissue around them, are proposed to retain two different patterns of behavior through cell division: contributing to repair or benefiting from others' repair while contributing less. would gain a survival or growth advantage only when enough nearby cells also contribute. A brief change in relative survival could therefore switch both tissues toward lasting recovery.

    Rests on: The preceding question supplies the idea of a lasting switch in damage between tissues. The endpoint supplies a mathematical model in which the advantage of contributing to repair depends on how common contributors are, conditional on their receiving preferential local benefits.

    Assumption

    The proposed mechanism assumes that the two behaviors persist through cell division and that retain enough local benefit to gain an advantage when common. These are explicit, testable premises; the supplied material does not establish them in aging tissue-supporting cells.

What is carried, and what is not. Two screened sources speak to separate ingredients: S6, in Nature Communications in 2026, reports that repeated injury weakens the capacity of mouse bone-marrow support cells to multiply and form bone, but does not establish competition between or damage passing between tissues; S10, in Journal of the Royal Society, Interface in 2019, reports that unequal sharing of , signals that influence cell growth, is required for a stable mixture of tumor cells in its account, but does not establish the proposed repair threshold in aging tissue. Neither source, nor the other supplied screened sources, establishes the sequence from changing to lasting recovery of two tissues.S6S10

Where the reasoning is carried by something unstated · 2
  • Master question. The search assumes that mutually reinforcing processes of aging may contain a shared link whose interruption benefits multiple systems. The supplied material does not establish such a link.
  • Hypothesis. The proposed mechanism assumes that the two behaviors persist through cell division and that retain enough local benefit to gain an advantage when common. These are explicit, testable premises; the supplied material does not establish them in aging tissue-supporting cells.
How a result here could mislead · 3
  • A change in the fraction of could reflect cells changing behavior in response to their surroundings rather than one persistent cell type outgrowing another. What closes it: The proposed common-environment check must establish that the behavioral differences persist through several divisions. Tracking descendants and measuring each population's growth and survival must distinguish changes in population abundance from changes in behavior.
  • Recovery after a survival-changing intervention could be credited to crossing the even if the intervention instead interrupts one of the rival routes: repeated cell death and replacement, spreading chemical damage to fats, or formation of damaging mineral particles. What closes it: The test must establish that lasting recovery depends on crossing the independently estimated while total cell number, starting damage, and daily burden are matched. The specified comparisons that preserve the cell ratio during a temporary pause in division, or hold constant while exchange between tissues continues, must be included; effects on the rival routes also require measurement.
  • An apparent dividing line between recovery and deterioration could be chosen after outcomes are known, while a negative result could merely mean that the intervention never moved the relevant cells across it. What closes it: Estimate the threshold from the separate cell-culture measurements before testing the connected tissues, and measure the actual cell proportions during and after intervention. Because the proposal depends on nearby contributors, an overall tissue fraction alone must not substitute for their local .

What would make this wrong. The mechanism would lose its basis if the two repair behaviors rapidly converged after several divisions in the same environment, or if contributors had no change from relative disadvantage to advantage as their starting fraction increased. Its explanation of the lasting switch would also fail if the switch persisted while was experimentally held constant and exchange between tissues continued, contrary to its explicit prediction.

What it would change. If the mechanism held, the search for a shared life-extension intervention would have a concrete candidate: briefly changing the of tissue-supporting cells so that repair continues to gain ground without continued treatment. Work on that goal would need to measure which cells benefit from repair and whether their relative abundance continues to change after treatment stops. Even successful recovery in a connected-tissue test would not establish longer lifespan, recovery across the whole body, or effectiveness in humans; the supplied testing outline does not specify a species or a duration that would establish those outcomes.

Sources read · 7

3 literature searches, 5 full texts, 5 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S2Background

JunB mediates enhancer/promoter activity of COL1A2 following TGF-beta induction. · Nucleic acids research · 2009

“These data are therefore relevant to the control of collagen type I in vivo both in embryonic development, in adult connective tissue homeostasis, and in tissue repair and scarring pathologies.”

Does not settle: Источник не устанавливает частотно-зависимый отбор между устойчиво наследуемыми вариантами клеток стромы, критическую долю восстановительных клеток, межтканевую передачу повреждения или устойчивое восстановление после краткого изменения выживаемости.

S3BackgroundAbstract only

From darkness to light: Targeting CAFs as a new potential strategy for cancer treatment. · International immunopharmacology · 2024

“Generally speaking, CAFs in cooperation with tumor cells can secrete various cytokines, proteins, growth factors, and metabolites to promote angiogenesis, mediate immune escape of tumor cells, enhance endothelial-to-mesenchymal transition, stimulate extracellular matrix remodeling, and preserve tumor cell stemness.”

Does not settle: Остаются открытыми частотно-зависимый отбор между наследуемыми вариантами поведения стромальных клеток, критическая доля восстановительных клеток, межтканевое поддержание повреждения и устойчивое восстановление двух тканей после краткого изменения выживаемости.

S5BackgroundAbstract only

Context-dependent PrPᶜ signaling in cancer stemness, mesenchymal stromal cell repair, and extracellular vesicle biology. · Pharmacological research · 2026

“The most consistent perturbation-based evidence linked PrPᶜ to hypoxic and oxidative stress resistance, mitochondrial integrity, senescence control, paracrine competence, and reparative activity.”

Does not settle: Источник оставляет открытыми частотно-зависимый отбор между наследуемыми вариантами клеточного поведения, критическую долю восстановительных клеток, связь повреждения между тканями и устойчивое восстановление двух тканей после краткого изменения выживаемости.

S6Partly answers it

Injury-driven stromal exhaustion disrupts intrinsic regenerative capability. · Nature communications · 2026

“Collectively, our findings demonstrate that repeated injury induces exhaustion in marrow reticular stromal cells, leading to compromised proliferation and osteogenesis.”

Does not settle: Источник описывает повторное повреждение и истощение стромальных клеток костного мозга у мышей. Он не устанавливает частотно-зависимый отбор, два устойчиво наследуемых варианта поведения, критическую долю восстановительных клеток, межтканевую динамику или возможность устойчиво восстановить ткани кратким изменением выживаемости клеток.

S7Background

Mechanisms on How Matricellular Microenvironments Sustain Idiopathic Pulmonary Fibrosis. · International journal of molecular sciences · 2025

“Schematic view of alternative pathways for alveolar injury–repair. After ADI recruitment, fibrillar ECM transition provides an environment for sustained activation of the integrated cell stress response.”

Does not settle: Источник не устанавливает частотно-зависимый отбор между наследуемыми вариантами клеток стромы, критическую долю восстановительных клеток, межтканевую динамику или устойчивое восстановление после краткого изменения выживаемости.

S8Background

Modulating DNA Polα Enhances Cell Reprogramming Across Species. · bioRxiv : the preprint server for biology · 2024

“Here, we find that reducing the level or activity of a replication component, DNA Polymerase α (Polα), facilitates cell reprogramming in diverse stem cell systems across species.”

Does not settle: Источник не устанавливает частотно-зависимый отбор между вариантами поведения стромальных клеток, критическую долю восстановительных клеток, межтканевую динамику повреждения, устойчиво наследуемые варианты поведения или механизм стабилизации SPV_1.

S10Background

Share, but unequally: a plausible mechanism for emergence and maintenance of intratumour heterogeneity. · Journal of the Royal Society, Interface · 2019

“We show that the emergence of a stable heterogeneous state in a tumour requires an unequal allocation of paracrine growth factors (public goods) between cells that produce them and those that merely consume them.”

Does not settle: Открытыми остаются участие клеток стромы в восстановлении тканей, два устойчиво наследуемых варианта их поведения, критическая доля восстановительных клеток, межтканевое повреждение, устойчивое восстановление двух тканей и эффект краткого изменения выживаемости.

The gap this hypothesis explains

Nothing is known here: the question has not been asked of this system.

Can breaking one link cross a damage threshold and restore aging tissues, beyond simply reducing daily harm?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Существует ли у стареющего организма , пересечение которого воздействием на одно звено вызывает устойчивое восстановление, и как отделит этот механизм от общей ?

What this question is asking

The question asks whether damage passing between tissues can become self-sustaining, and whether interrupting one causal link can switch an aging organism back toward lasting recovery. It assumes that interacting processes form a complete feedback loop, in which damage eventually feeds back to reinforce its own cause; the supplied material does not establish that full loop. The proposed signs of recovery are shrinking repeated peaks of damage, restoration of a protective tissue barrier within the first day, and a delay between responses in different systems that stays within specified limits across successive daily cycles. The decisive distinction is whether recovery follows from stopping the loop from sustaining itself or simply from reducing the total harmful burden each day. The supplied material names linked-organ and timing measurements as available tools, but does not describe their validation, the relevant barrier, or the acceptable timing limits.

What the terms mean
Self-sustaining damage
Damage whose consequences generate enough further damage to keep the process operating. The question asks whether this happens between tissues, rather than merely whether injury persists while an external harmful exposure continues.
Feedback loop or positive feedback
A chain of effects that returns to influence its starting point; positive feedback reinforces the initial change. A connection from one tissue to another establishes only part of a loop unless a returning influence is also established.
Causal link
A connection in which changing one process changes a downstream process. The proposed intervention targets one such connection within the claimed damage loop.
Damage threshold or tipping point
A boundary between different patterns of behavior, here damage that fades and damage that maintains itself. The supplied question proposes such a boundary but gives no established value or measurement for it.
Daily harmful burden
The total harm imposed over a day, as invoked by the question. The supplied material does not specify its components or how they would be combined into a measurement.
Tissue barrier and gut barrier
A layer of cells that controls movement between compartments, such as between the gut’s contents and the rest of the body. Barrier function varies in degree; a leaky gut means impaired control, rather than necessarily a complete physical break.
Delay between system responses
The elapsed time between a change in one biological system and a corresponding change in another. The question treats stable timing over daily cycles as a recovery criterion but does not provide acceptable limits.
Linked-organ and timing measurements
Tools that the supplied gap description says can investigate connections between organ systems and the timing of their responses. Their construction, capabilities, and validation are not supplied.
Liver scarring
Accumulation of scar tissue in the liver, also called hepatic fibrosis. S2 describes interacting injury processes that promote it, which provides a narrower example of self-amplifying damage.
Inflammation
A biological response to injury or threat that can also contribute to damage when it persists or becomes excessive. The sources discuss it in several settings, which do not automatically establish the same mechanism.
Regulated cell death
Cell death carried out through an organized biological process. S3 concerns a threshold enabling such a process within cells, not a demonstrated recovery threshold between tissues.
Macrophages
Immune cells involved in responding to injury and clearing material. They are the cellular setting identified in the supplied summary of S3.
Atrial fibrillation
An irregular heart rhythm involving the heart’s upper chambers. Susceptibility to this rhythm is the outcome reported in S5, rather than a measurement of overall recovery from aging.
Signaling component
A molecule or biological process that helps transmit an effect within or between cells. S5 reports benefits from blocking particular components of the gut–heart connection.
Cellular senescence
A cell state commonly characterized by a lasting halt in division and changes in cell function. It is not synonymous with aging of an entire organism; S7 concerns this state in the intestine.
Polystyrene particles
Small pieces of a type of plastic. Their exposure, together with particular dietary conditions, defines the injury setting described in S7.
Microorganism communities
Groups of microscopic organisms living in a particular environment, including within or on the body. S6 discusses how aging-related changes in these communities connect with bodily dysfunction.
Coronavirus disease 2019
The infectious disease discussed in S8. Its reported progression provides a different disease context for barrier failure and multiple-organ dysfunction.
Lactylation
A chemical modification of proteins. S9 discusses its inhibition as a way of suppressing a reinforcing pathway associated with brain inflammation.
Microglia
Immune cells in the brain. Excessive activation of these cells is part of the inflammation mechanism described in S9.
Alzheimer’s disease model
A research system representing selected features of a disease that damages brain function. Findings in that model do not by themselves establish effects throughout an aging organism.
What the question takes for granted
Premise only partly supported
Interacting damage processes in an aging organism form a complete, self-amplifying loop between tissues that can be distinguished from the total daily harmful burden; linked-organ and timing measurements already provide tools for investigating it.

The assumption is that injury can pass between tissues and return to worsen the injury that started the sequence. A protective tissue barrier is one proposed part of this sequence, while the time between responses in different systems is a proposed measurement of their connection. If this assumption held, improvement after interrupting one connection could potentially be interpreted as a change in the cycle itself, rather than only as less harm entering the system.

The read sources support narrower elements: S2 describes a self-amplifying network in chronic liver injury, S5 reports that interventions affecting the gut–heart connection reduce susceptibility to an abnormal heart rhythm in mice, and S9 reports suppression of a reinforcing process within a brain-disease model. These do not establish a complete self-sustaining loop between tissues in an aging organism. S4 explicitly presents the threshold mechanism as a hypothesis. None of the supplied excerpts validates the named measurement tools or establishes a way to separate loop interruption from reduced daily harmful burden.S2S4S5S9

The same question asked without the part nothing read establishes:

  • Does interrupting one causal connection between tissues in an aging organism produce lasting recovery through a damage threshold, beyond the effect of reducing total daily harm?
  • Do connected tissues in an aging organism continue to reinforce one another’s damage after the initiating harmful burden subsides?
What turns on the answer
  • A threshold permits lasting recovery If interrupting one link reduces reinforcement below the level needed to sustain damage, each successive round of damage would weaken. Recovery across connected tissues would then reflect a change in the feedback process, provided that reduced daily harm alone does not explain it.
  • Improvement reflects reduced daily harm If the intervention reduces the harmful burden without changing a self-sustaining process, less damage could occur while that reduction continues. The improvement would not establish that a threshold was crossed or that recovery would persist when the burden returned.
  • One interrupted link does not restore the system If damage continues to sustain itself despite interruption of the chosen link, improvement in one tissue would not establish recovery across the connected tissues. That outcome would leave the proposed single-link route to lasting recovery unestablished, without by itself ruling out every possible damage threshold.
Why it matters

Under the proposed mechanism, damage in one tissue affects another, and a returning effect reinforces damage in the first tissue. If that reinforcement can maintain damage, reducing an initiating harmful exposure might leave the cycle operating. Interrupting an essential link could then allow damage to subside across the connected tissues, but lasting recovery is a further claim that needs its own evidence. Mistaking a temporary reduction in daily harm for this transition would turn a limited improvement into an unsupported claim that the organism had entered a durable recovery state.

What is already established

RL-1 и RL-2 позволяют исследовать связи, но не установлен.

What would have to be true

Повторные пики повреждения затухают; восстанавливается в первые сутки, остаётся в заданных пределах при последовательных суточных циклах.

What is missing

Отсутствует экспериментально установленный переход между затухающим и самоподдерживающимся повреждением, управляемый одним причинным звеном.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

возникает из между двумя устойчиво наследуемыми вариантами поведения : участием в восстановлении общей тканевой и использованием результатов чужого восстановления с меньшими собственными затратами. получают преимущество только при достаточной доле таких же соседей, поскольку совместное производство и компонентов создаёт локально благоприятную . Ниже преимущество получают клетки с низким вкладом в восстановление. Межтканевое повреждение дополнительно ухудшает условия для и поддерживает этот . Краткое изменение в одном звене, переводящее долю выше порога, запускает устойчивое восстановление обеих тканей. Предполагаемая «серебряная пуля» меняет направление в клеточном сообществе и тем самым стабилизирует SPV_1.

Where the idea comes from

The hypothesis borrows a result from another field. This is what it borrows, and from where.

, . dp/dt = p(1-p)(π_R-π_E), где t обозначает время в сутках; p обозначает долю R; 1-p обозначает долю клеток E с низким вкладом; π_R и π_E обозначают измеренные соответствующих в сутки. Минимальная проверяемая модель задаёт π_R = r + bp - c и π_E = r. Здесь r обозначает общий базовый темп, c обозначает потерю собственного темпа из-за участия в восстановлении, b обозначает дополнительное преимущество R при взаимодействии с другими R; b и c имеют сутки^-1. При 0<c<b неустойчивый порог равен p*=c/b. Предположение о преимуществе R требует и ; при полностью одинаковом доступе обеих к эта неприменима. Эмпирический прецедент производителей общего получен для в опухолевых клетках: [Archetti и соавторы, , 2015](https://pmc.ncbi.nlm.nih.gov/articles/PMC4330744/). Конкретная стареющей является новым предположением, а не результатом той работы.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

При одинаковых общей численности клеток, начальном повреждении и исходная доля определяет противоположные долгосрочные траектории. Ниже независимо оценённого порога эта доля уменьшается, выше него возрастает; вслед за этим соответственно усиливаются или затухают повторные повреждения. Краткое вмешательство даёт устойчивый результат только при пересечении . Одинаковое временное обеих , сохраняющее их соотношение, устойчивого переключения не вызывает. При экспериментально постоянном предполагаемый переход исчезает, даже если продолжается.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable directional changes on either side of an independently estimated threshold, a condition for a lasting intervention effect, and conditions under which switching or the transition is absent. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Сначала нужны выделенных стромальных и измерение их или выживания при разных исходных соотношениях. оценивают до опыта в межтканевой системе. Наследуемость различий проверяют после нескольких делений в одинаковой . Если различия быстро исчезают, модель этих вариантов теряет основание.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

При одинаковых общей численности клеток, начальном повреждении и исходная доля определяет противоположные долгосрочные траектории. Ниже независимо оценённого порога эта доля уменьшается, выше него возрастает; вслед за этим соответственно усиливаются или затухают повторные повреждения. Краткое вмешательство даёт устойчивый результат только при пересечении . Одинаковое временное обеих , сохраняющее их соотношение, устойчивого переключения не вызывает. При экспериментально постоянном предполагаемый переход исчезает, даже если продолжается.

  • What would separate them

    Repair-driven cell division may sustain a cycle of damage between the gut and blood vessels predicts: В связанной модели кишечника и после удаления исходного повреждающего стимула новые очаги повреждения преимущественно возникают в потомках клеток, вступивших в деление после первичного эпизода. Обратимая только в принимающего звена на один цикл восстановления прекращает последующие волны в обеих тканях. Эффект сохраняется после возобновления деления и при прежней . Численность первоначальных при этом может оставаться прежней. Если повреждение продолжает распространяться при подтверждённой , а прекращается при подавлении или образования , гипотеза отвергается в пользу соответствующего соперника.

  • What would separate them

    A lipid oxidation chain may sustain damage between gut and vascular tissue predicts: каждого показывает последовательное образование новых сначала в принимающей ткани, затем в исходной после возврата . Повреждающая активность регенерируется при , превышая остаточную активность первоначального материала с учётом его . Она сохраняется при и отсутствии , но прекращается после избирательного в . на время исчезновения этой активности обеспечивает устойчивое восстановление после повторного соединения. Если эффект требует или переносится очищенной при удалённых , гипотеза отвергается.

  • What would separate them

    Calcium phosphate particle growth may sustain damage between the gut and blood vessels predicts: При одинаковых , , белковом составе и внешних нагрузках малая добавка охарактеризованных запускает длительное образование новых частиц и повторные пики повреждения. Частицы с подавленной способностью к росту при сопоставимых размере и такого эффекта не дают. Избирательное прекращает передачу повреждения после восстановления исходных концентраций . Добавление новых вновь запускает цикл после отмены вмешательства. Зависимость от сохраняется при подавлении деления клеток; при сохранённой минеральной активности одно устранение устойчивого выключения не обеспечивает.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.